Ayala Pharmaceuticals, Inc. (NASDAQ:ADXS – Get Free Report)’s share price traded up 32.1% on Wednesday . The stock traded as high as $0.65 and last traded at $0.6365. 33,313 shares changed hands during mid-day trading, an increase of 139% from the average session volume of 13,938 shares. The stock had previously closed at $0.4820.
Ayala Pharmaceuticals Stock Up 32.1%
The stock has a fifty day simple moving average of $0.18 and a 200 day simple moving average of $0.10. The firm has a market capitalization of $37.75 million, a P/E ratio of -0.08 and a beta of 1.31.
Ayala Pharmaceuticals Company Profile
Ayala Pharmaceuticals is a clinical-stage biotechnology company focused on the development of innovative immunotherapies for cancer. The company’s core technology leverages a proprietary attenuated Listeria monocytogenes–based platform to deliver tumor-associated antigens directly to antigen-presenting cells, stimulating potent T-cell responses. By harnessing the body’s own immune system, Ayala aims to achieve durable anti-tumor activity while maintaining a favorable safety profile.
The company’s pipeline comprises several lead candidates targeting a variety of solid tumors.
Read More
- Five stocks we like better than Ayala Pharmaceuticals
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
